Aevi Genomic Medicine Inc. (GNMX) Fundamentals

Medgenics is a clinical-stage biopharmaceutical company involved mainly in genomic medicine. Genomic medicine involves the usage of individual's genomic information to decide upon clinical care. This medical discipline is used in the fields of oncology, pharmacology, rare and undiagnosed diseases, and infectious diseases. Medgenics' partner is the Center for Applied Genomics at the Children's Hospital of Philadelphia, with which it works to develop drugs by implementing genomics medicine.
SHARE INFORMATION
Market CapUS$ 12,892,716
Shares Outstanding77,713,782
Float22,773,062
Percent Float29.3%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0.00
Latest Fiscal RevenueUS$ 0
Latest Fiscal EPSUS$ -0.51
Latest Fiscal Date2018-12-31
DIVIDENDS
Dividend (3 Years)US$ 0.00
Dividend (5 Years)US$ 0.00
Ex Dividend Date-
Dividend RateUS$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions41
Institutional Holdings Date2020-01-31
Institutional Bought Previous 3 Months1,001,456
Institutional Holdings Percent9.3%
Institutional Sold Previous 3 Months612,770
Insider Holdings Date-
Insider Bought Previous 3 Months-
Insider Holdings Percent0.0
Insider Sold Previous 3 Months-
Insider Shares Owned10,239,610
TRADING INFO
52 Week HighUS$ 0.35
52 Week LowUS$ 0.11
52 Week High ChangeUS$ -21.19
21 Day Moving AverageUS$ 0.1659
21 Day Extended Moving AverageUS$ 0.16758
50 Day Moving AverageUS$ 0.1761
50 Day Extended Moving AverageUS$ 0.16761
200 Day Moving AverageUS$ 0.16645
200 Day Extended Moving AverageUS$ 0.22827
10 Day Average Volume-
20 Day Average Volume-
30 Day Average Volume214,673
50 Day Average Volume1,449,920
Alpha-0.040381
Beta1.1656
Standard Deviation0.228347
R20.033491
7 Day Price ChangeUS$ 0.00
7 Day Percent Change0.0%
21 Day Price ChangeUS$ 0.00
21 Day Percent Change0.0%
30 Day Price ChangeUS$ 0.00
30 Day Percent Change0.0%
Month to Date Price ChangeUS$ 0.00
Month to Date Percent Change0.0%
Quarter to Date Price ChangeUS$ 0.0199
Quarter to Date Percent Change13.63%
180 Day Price ChangeUS$ -0.0011
180 Day Percent Change-0.66%
200 Day Price ChangeUS$ -0.014
200 Day Percent Change-7.78%
Year to Date Price ChangeUS$ 0.0199
Year to Date Percent Change13.63%

Aevi Genomic Medicine Inc. (GNMX) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
RevenueUS$ 0
Revenue Per ShareUS$ 0.00
Revenue (3 Years)US$ 0.00
Revenue (5 Years)US$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book-3.70
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio0.70
Leverage Ratio29.80
Quick Ratio0.60
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio0.00
Enterprise ValueUS$ 10,511,716
Price to Sales0.00
Price to Free Cash-1.10
PE High Last 5 Years0.00
Price To Book24.70
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book-3.70
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-176.30
Return on Equity-405.79
Return on Capital-372.06

Aevi Genomic Medicine Inc. (GNMX) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEO-
Emplyoees14
Last AuditUE
CIK0001138776
IndustryBiotechnology
SectorHealthcare
NAICSBiological Product (except Diagnostic) Manufacturing(325414)
CONTACT INFO
Address435 Devon Park Drive
Suite 715
Wayne, PA 19087
Websitehttp://www.aevigenomics.com
Facsimile-
Telephone+1 610 254-4201
EmailChris.Brinzey@westwicke.com
Your Recent History
NASDAQ
GNMX
Aevi Genom..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:au D:20220520 22:52:23